An open label, single arm pilot study of OncoSil™, administered to study participants with unresectable locally advanced pancreatic adenocarcinoma, given in combination with FOLFIRINOX or gemcitabine+nab-paclitaxel chemotherapies

Project: Research

Project Description

NMA HREC Reference Number: HREC/16/MonH/408
Monash Health Ref: 16-0000-580A
StatusActive
Effective start/end date4/01/193/01/24